Amendment to FDA Memorandum Circular No. 2013-016 "Guidelines on Electronic Registration for Training and Seminars (E-Course Registration)"

In the interest of public service delivery, with respect to the payment of corresponding fees, Procedure Nos. 5, 6, 6.1 and 6.2 of FDA Memorandum Circular No. 2013-16 are hereby amended as follows:

Procedure No. 5 to read as:

"Pay  the corresponding fee at any DBP branch using the Account Name: Food and Drug Administration Special Fund, Account No.: DBP 0430-013669-030.    The ASSESSMENT FORM xxx..."

Procedure No. 6, 6.1 and 6.2 to delete the words: "Original Receipt (OR)"

Likewise, Validated Deposit Slip is considered as proof of payment; hence, issuance of Official Receipt (OR) in the FDA is no longer necessary.

All other provisions of FDA Memorandum Circular No. 2013-16 are still in effect.

Attachments:
Download this file (FMC2013-024.pdf)FMC2013-024.pdf

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter